These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10360961)

  • 1. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand.
    Kawano T; Tanaka Y; Shimizu E; Kaneko Y; Kamata N; Sato H; Osada H; Sekiya S; Nakayama T; Taniguchi M
    Int Immunol; 1999 Jun; 11(6):881-7. PubMed ID: 10360961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
    Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
    Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKT TCR recognition of CD1d-α-C-galactosylceramide.
    Patel O; Cameron G; Pellicci DG; Liu Z; Byun HS; Beddoe T; McCluskey J; Franck RW; Castaño AR; Harrak Y; Llebaria A; Bittman R; Porcelli SA; Godfrey DI; Rossjohn J
    J Immunol; 2011 Nov; 187(9):4705-13. PubMed ID: 21964029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells.
    Schümann J; Voyle RB; Wei BY; MacDonald HR
    J Immunol; 2003 Jun; 170(12):5815-9. PubMed ID: 12794105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.
    Gadola SD; Koch M; Marles-Wright J; Lissin NM; Shepherd D; Matulis G; Harlos K; Villiger PM; Stuart DI; Jakobsen BK; Cerundolo V; Jones EY
    J Exp Med; 2006 Mar; 203(3):699-710. PubMed ID: 16520393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of natural killer T cells in antitumor immunotherapy.
    Hong C; Park SH
    Crit Rev Immunol; 2007; 27(6):511-25. PubMed ID: 18197797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
    Wun KS; Borg NA; Kjer-Nielsen L; Beddoe T; Koh R; Richardson SK; Thakur M; Howell AR; Scott-Browne JP; Gapin L; Godfrey DI; McCluskey J; Rossjohn J
    J Exp Med; 2008 Apr; 205(4):939-49. PubMed ID: 18378792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human NKT cells express granulysin and exhibit antimycobacterial activity.
    Gansert JL; Kiessler V; Engele M; Wittke F; Röllinghoff M; Krensky AM; Porcelli SA; Modlin RL; Stenger S
    J Immunol; 2003 Mar; 170(6):3154-61. PubMed ID: 12626573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15.
    van der Vliet HJ ; Nishi N; Koezuka Y; von Blomberg BM ; van den Eertwegh AJ ; Porcelli SA; Pinedo HM; Scheper RJ; Giaccone G
    J Immunol Methods; 2001 Jan; 247(1-2):61-72. PubMed ID: 11150537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ex vivo expansion of Valpha24 natural killer T cells with alpha-galactosylceramide].
    Huang Y; Jiang EL; Zhou Z; He Y; Wang M; Liu QG; Zhai WJ; Han MZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):315-20. PubMed ID: 16038267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size.
    Matsuda JL; Gapin L; Fazilleau N; Warren K; Naidenko OV; Kronenberg M
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12636-41. PubMed ID: 11592984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The paradox of immune molecular recognition of alpha-galactosylceramide: low affinity, low specificity for CD1d, high affinity for alpha beta TCRs.
    Cantu C; Benlagha K; Savage PB; Bendelac A; Teyton L
    J Immunol; 2003 May; 170(9):4673-82. PubMed ID: 12707346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.
    Gadola SD; Dulphy N; Salio M; Cerundolo V
    J Immunol; 2002 Jun; 168(11):5514-20. PubMed ID: 12023346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected].
    Stanic AK; Shashidharamurthy R; Bezbradica JS; Matsuki N; Yoshimura Y; Miyake S; Choi EY; Schell TD; Van Kaer L; Tevethia SS; Roopenian DC; Yamamura T; Joyce S
    J Immunol; 2003 Nov; 171(9):4539-51. PubMed ID: 14568927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex.
    Sidobre S; Naidenko OV; Sim BC; Gascoigne NR; Garcia KC; Kronenberg M
    J Immunol; 2002 Aug; 169(3):1340-8. PubMed ID: 12133957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.